USPTO serial 98305479
KORRO
Reviewed by CopyMark Law Group
Status 733Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- SOLANO, CARLITA JAYE
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with KORRO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $449*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Cambridge, MA, US
Cambridge, MA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tiffany D. Gehrke
Tiffany D. Gehrke Marshall, Gerstein & Borun LLP233 South Wacker Drive, Suite 6300Chicago, IL 60606United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of genetic diseases; Pharmaceutical products for cell therapy to treat genetic diseases; Medical and scientific research in the field of pharmaceuticals, genetics, gene editing, and genetic diseases | ACTIVE | — |
| 040 | Custom manufacture of biomedical compounds comprised of nucleotide polymers and biomedical compounds comprised of ribonucleic acid polymers all for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders for others; Custom manufacture and processing of human cells for medical purposes for others; Treatment of therapeutic cells for others, namely, pharmacological treatment and processing of therapeutic cells to modify their function for therapeutic purposes | ACTIVE | — |
| 042 | Pharmaceutical research and development; Pharmaceutical research and development in the fields of gene therapies, gene editing, drug discovery and development; Pharmaceutical research and development incorporating artificial intelligence; Pharmaceutical research and development incorporating genetic learning; Scientific and industrial research; Scientific and industrial research incorporating artificial intelligence; Scientific and industrial research in the field of gene therapies, gene editing, drug discovery and development incorporating genetic learning; Medical and scientific research in the field of pharmaceuticals, genetics, gene editing, and genetic diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 15, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 14, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Oct 14, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Oct 14, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 4, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 3, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 3, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 3, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 4, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 4, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 4, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 9, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 8, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 8, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 8, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 3, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 3, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 3, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 15, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 20, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 20, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 31, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 16, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 16, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 16, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 16, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 16, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 9, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 7, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 8, 2023 | NWAP | NEW APPLICATION ENTERED | — |